Assessing women's preferences for postpartum blood clot prevention
Assessing Women's Preferences for Postpartum Thromboprophylaxis: the PREFER-PostPartum
This study is trying to find out what women who have recently given birth prefer when it comes to preventing blood clots during the postpartum period.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 52 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Fondation Hôpital Saint-Joseph Academic / other |
| Locations | 1 site (Paris) |
| Trial ID | NCT05318547 on ClinicalTrials.gov |
What this trial studies
This study evaluates women's preferences regarding thromboprophylaxis during the postpartum period to prevent venous thromboembolism (VTE). It focuses on women who are either pregnant or have recently given birth, assessing their risk factors for VTE and their willingness to use low-molecular-weight heparin as a preventive measure. The study employs techniques such as standard-gamble and time trade-off to gauge preferences and inform clinical decision-making. By understanding these preferences, the study aims to enhance patient-centered care in postpartum thromboprophylaxis.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 18 and older who are either pregnant or within 7 days postpartum and fluent in French.
Not a fit: Patients who have experienced fetal or neonatal death or are under legal guardianship may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and effective prevention strategies for postpartum VTE, improving maternal health outcomes.
How similar studies have performed: While there is existing research on thromboprophylaxis, this study's focus on women's preferences in the postpartum context is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women aged ≥18 years * Ongoing pregnancy or in the early postpartum period (within 7 days of delivery) * Participants may be with or without prior VTE or major bleeding, and with or without previous/current use of postpartum TPX. * Fluency in French * Women are able and willing to give free, informed and written consent Exclusion Criteria: * Fetal or neonatal death, in order not to bother women during their mourning. * Women under tutorship or curatorship * Women deprived of liberty * Women under court protection There will be no further exclusion criteria, to maximize the external validity of the study.
Where this trial is running
Paris
- Groupe Hospitalier Paris Saint-Joseph — Paris, France (Recruiting)
Study contacts
- Principal investigator: Justine P Hugon Rodin, MD — Fondation Hôpital Saint-Joseph
- Study coordinator: Justine Hugon Rodin, MD
- Email: jhugon@ghpsj.fr
- Phone: 144123934
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.